Marcus Webb

Capsule Versus Tincture: What EBC-46 Blushwood Berry Users Report About Format Preference

What EBC-46 supplement users say about capsule versus tincture formats — convenience, taste, dose precision, and how the choice intersects with cost, travel, and how a household uses the product day to day.

Pollination Biology of Fontainea picrosperma: How the Blushwood Tree Is Pollinated in the Wet Tropics

What is known about the pollinators of Fontainea picrosperma, why dioecious tropical understorey trees pose specific pollination challenges, and what cultivation projects mean for the species long-term.

Population Pharmacokinetic Modelling of Tigilanol Tiglate (EBC-46): What the Exposure Data Tells Trial Designers

How population PK modelling supports tigilanol tiglate clinical trial design, what the published exposure data shows about local versus systemic levels, and where the modelling assumptions still need work.

Endoplasmic Reticulum Calcium Release After EBC-46: How Tigilanol Tiglate Mobilises Intracellular Ca²⁺ Stores

How tigilanol tiglate triggers calcium release from the endoplasmic reticulum via PKC-coupled signalling, and why this Ca²⁺ flux contributes to the necrotic cell-death programme EBC-46 produces.

South Korea's MFDS Framework and Health Functional Foods: How EBC-46 Botanical Supplements Are Classified

How South Korea's MFDS regulates botanical health functional foods, and where EBC-46 blushwood berry extract supplements would fit within this dual-track framework for buyers comparing markets.

Consumer Reports

Tincture Taste Profile: What EBC-46 Blushwood Berry Users Describe and How It Shifts Between Batches

Blushwood berry tincture has a recognisable taste profile that varies with batch and carrier solvent. Here is what experienced EBC-46 users report about flavour, aftertaste, and palatability.

Natural Source

Seed Dormancy and Germination in Fontainea picrosperma: Why Blushwood Berry Seeds Are Slow and Recalcitrant

Blushwood berry seeds (Fontainea picrosperma) are slow-germinating and partly recalcitrant. This article reviews dormancy mechanisms and what they mean for propagation.

Human Trials

Bayesian Dose-Escalation Designs in Tigilanol Tiglate Phase I Trials: How EBC-46 Researchers Find a Safe Working Dose

Phase I trials of tigilanol tiglate use Bayesian and modified 3+3 dose-escalation schemes. This article explains how those statistical designs decide the next-cohort dose.

Mechanism of Action

Ferroptosis and EBC-46: How Tigilanol Tiglate Intersects With Iron-Dependent, Lipid-Peroxidation Cell Death

Ferroptosis is an iron-dependent form of regulated cell death driven by lipid peroxidation. This article reviews the evidence linking EBC-46 mechanism studies to ferroptotic signalling.

Regulatory

India CDSCO and AYUSH Frameworks: How EBC-46 Blushwood Berry Supplements Are Classified

India regulates botanical supplements through CDSCO and the Ministry of AYUSH. This explainer shows where EBC-46 blushwood berry products sit in that framework in 2026.

Consumer Reports

Dropper Measurement Variability in Blushwood Berry Tinctures: What EBC-46 Users Report About Dosing Consistency

How much actual liquid a glass dropper delivers per squeeze varies — what blushwood berry tincture users report about measurement consistency and practical workarounds.

Natural Source

Phorbol Ester Biosynthesis in Fontainea picrosperma: How the Blushwood Tree Makes Tigilanol Tiglate

What is known about the biosynthetic pathway producing tigilanol tiglate and related daphnane esters in Fontainea picrosperma seed, and why the plant likely makes these compounds.